Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.

@article{Battistella2011SafetyOA,
  title={Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke.},
  author={Valeria Battistella and Gabriel de Freitas and Lea Mirian Barbosa da Fonseca and Daniel Richard Mercante and Bianca Gutfilen and Regina Coeli dos Santos Goldenberg and Juliana Vieira Dias and Ta{\'i}s Hanae Kasai-Brunswick and Eduardo Wajnberg and Paulo Henrique Rosado-de-Castro and Soniza Vieira Alves-Leon and Rosalia Mendez-Otero and Charles Andr{\'e}},
  journal={Regenerative medicine},
  year={2011},
  volume={6 1},
  pages={45-52}
}
AIMS To assess the safety and feasibility of intra-arterial transplantation of autologous bone marrow mononuclear cells in patients with middle cerebral artery ischemic stroke within 90 days of symptom onset. PATIENTS & METHODS Six patients were included in the study, and they received 1-5 × 10(8) bone marrow mononuclear cell and were evaluated using blood tests, neurological and imaging examination before treatment, and 1, 3, 7, 30, 60, 90, 120 and 180 days after transplantation… CONTINUE READING